Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic × pegfilgrastim × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Rhabdomyosarcoma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Burkitt Lymphoma 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

fludarabine 6 Whole-Body Irradiation 6 Cyclophosphamide 6 Mycophenolic Acid 5 fludarabine phosphate 4 Sirolimus 3 Cyclosporine 3 ibrutinib 2 acalabrutinib 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Cyclosporins 2 venetoclax 1 treosulfan 1 tafasitamab 1 selinexor 1 obinutuzumab 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Stem Cell Transplantation 1 Rituximab 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Patient Reported Outcome Measures 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡